As of Aug 23
| -1.10 / -0.84%|
The 26 analysts offering 12-month price forecasts for Celgene have a median target of 154.50, with a high estimate of 175.00 and a low estimate of 102.00. The median estimate represents a +19.59% increase from the last price of 129.19.
The current consensus among 29 polled investment analysts is to Buy stock in Celgene. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.